Pfizer Halts Lung Cancer Trials Of Toll-Like Receptor Agent

Fate of other oncology trials of the TLR9 candidate Pfizer licensed from Coley has not been made public.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet